MIRIKIZUMAB-INDUCED TRANSCRIPTOME CHANGES IN PATIENT BIOPSIES AT WEEK 12 ARE MAINTAINED THROUGH WEEK 52 IN PATIENTS WITH ULCERATIVE COLITIS
Travis Johnson 1
Boyd Steere 2
Pengyue Zhang
Yong Zang
Richard Higgs
Klaus Gottlieb
Walter Reinisch 3
Julian Panés 4
Venkatesh Krishnan
1 Indiana University Clinical and Translational Sciences Institute (CTSI), Indianapolis, United States
2 Eli Lilly and Company, Indianapolis, United States
3 Medical University of Vienna, Vienna, Austria
4 Hospital Clinic of Barcelona, Barcelona, Spain
Session
IBD: Clinical trials poster I
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]